← Back to Search

PrEP Master Adherence Intervention for HIV Prevention

N/A

Waitlist Available

Led By Jessy G Dévieux, Ph.D.

Research Sponsored by Florida International University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial will test an intervention program to improve HIV PrEP utilization among women of color who are at substantial risk for HIV, including alcohol use.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Participants receiving 3 Medication Appointments

Number of Participants reporting Adherence to HIV testing recommendation

Percentage Adherence to PrEP Medication

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: PrEP Master Adherence InterventionExperimental Treatment1 Intervention

The intervention consists of an introductory session and 4 individual sessions led by the PrEP Master, over an 8 week period. Between the sessions, the PrEP Master will conduct weekly check-in calls to participants to encourage adherence and assist with difficulties. During the weekly check-in, side effects and their impact will be assessed using assessment measures.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

PrEP Master Adherence Intervention

2019

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Florida International UniversityLead Sponsor

99 Previous Clinical Trials

17,267 Total Patients Enrolled

Jessy G Dévieux, Ph.D.Principal InvestigatorFlorida International Univ.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

If I qualify, may I participate in this research project?

"This study is looking for 120 individuals between 18-45 years old who identify as African American, Hispanic/Latina, or Haitian with a history of HIV prevention. Other inclusion criteria include: self-reported or parent-reported sexual risk factors (i.e. previous STI, inconsistent condom use, transactional sex, HIV infected partner); 18+ years of age; female; history of alcohol or drug use in last 3 months; no uncleared Prep contraindications; and no psychosis."

Answered by AI

Are enrollments currently being taken for this research project?

"Yes, that is accurate. According to the information available on clinicaltrials.gov, this trial is still looking for individuals to take part. The study was originally posted on 5/31/2019, with the most recent update being on 9/15/2022. The trial is enrolling 120 participants at 1 site."

Answered by AI

If an person is above the age of majority, can they participate in this research project?

"The target recruitment pool for this study are individuals who are younger than 45 and older than 18."

Answered by AI

How large is the patient sample size for this research?

"That is correct. The information available on clinicaltrials.gov supports that this clinical trial is currently looking for patients. The study was originally posted on 5/31/2019 and was last edited on 9/15/2022. The trial is looking for 120 participants between 1 locations."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Optimizing PrEP Utilization Among Alcohol and Other Drug (AOD) Using Women of Color

jessy g devieux 2019. "Optimizing PrEP Utilization Among Alcohol and Other Drug (AOD) Using Women of Color". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04018651.